CymitQuimica logo
MEK

MEK

MEK é uma quinase de dupla especificidade que desempenha um papel central na via de sinalização MAPK/ERK, ativando ERK por meio de fosforilação. A sinalização de MEK é crucial para a regulação do crescimento, sobrevivência e diferenciação celular. A atividade anômala de MEK tem sido implicada em vários tipos de câncer e distúrbios do desenvolvimento, tornando-a um importante alvo terapêutico. Na CymitQuimica, oferecemos uma variedade de inibidores e moduladores de MEK para apoiar sua pesquisa em oncologia, sinalização celular e desenvolvimento terapêutico.

Foram encontrados 75 produtos para "MEK".

produtos por página.
  • Lidocaine Hydrochloride hydrate

    CAS:
    Lidocaine Hydrochloride hydrate is an amide local anesthetic, has anti-inflammatory property.
    Fórmula:C14H22N2O·HCl·H2O
    Pureza:99.95%
    Cor e Forma:Solid
    Peso molecular:288.82
  • PD 198306

    CAS:
    PD 198306: a MEK inhibitor with antihyperalgesic properties, reduces Streptozocin-boosted active ERK1.
    Fórmula:C18H16F3IN2O2
    Pureza:99.66%
    Cor e Forma:Solid
    Peso molecular:476.23
  • Lidocaine

    CAS:
    Lidocaine, an amide local anesthetic, reduces pain and inflammation by dampening ICAM-1, cytokines, and neutrophil influx.
    Fórmula:C14H22N2O
    Pureza:99.88% - >99.99%
    Cor e Forma:White Solid
    Peso molecular:234.3373
  • MAPK Inhibitor Library


    A unique collection of xnum cancer cell differentiation inducing compounds for high throughput and high content screening;
    Cor e Forma:Odour Solid
  • FDA-Approved Kinase Inhibitor Library


    A unique collection of xnum kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.
    Cor e Forma:Liquid
  • Luvometinib-d


    Luvometinib-d is a deuterium-labeled version of Luvometinib, which is a mitogen-activated protein kinase (MEK) inhibitor with antitumor properties.
  • MEK1/2-IN-3


    MEK1/2-IN-3 (Compound M15) is an inhibitor of MEK1, with an IC50 value of 10.29 nM. It effectively suppresses tumor cell proliferation and migration, induces apoptosis, and exhibits good liver microsomal stability. MEK1/2-IN-3 is applicable in the study of solid tumors.
    Fórmula:C28H23F3IN3O4
    Cor e Forma:Solid
    Peso molecular:649.4
  • Cobimetinib (R-enantiomer)

    CAS:
    Cobimetinib R-enantiomer is the less active R-enantiomer of Cobimetinib which is a selective MEK inhibitor.
    Fórmula:C21H21F3IN3O2
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:531.318
  • MS432


    MS432 is a highly selective PD0325901-based VHL-recruiting PROTAC degrader for MEK1 and MEK2.
    Fórmula:C50H65F3IN7O6S
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:1076.06
  • MEK4 inhibitor-1

    CAS:
    MEK4 inhibitor-1 targets MEK4 enzyme in pancreatic cancer, IC50=61 nM.
    Fórmula:C13H10FN3O2S
    Cor e Forma:Solid
    Peso molecular:291.3
  • NST-628

    CAS:
    NST-628 is a pan-RAF-MEK molecular glue that prevents RAF from phosphorylating and activating MEK. NST-628 inhibits the RAF-MEK signaling complex.
    Fórmula:C22H18F2N4O5S
    Pureza:98.62% - 98.86%
    Cor e Forma:White Solid
    Peso molecular:488.46
  • U0124

    CAS:
    Inactive analog of U0126(MEK-1/2 inhibitor), used as a negative control
    Fórmula:C8H10N4S2
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:226.32
  • Midkine Protein, Human, Recombinant (His & Avi)


    Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic acid-responsive gene during embryogenesis, but currently viewed as
    Pureza:> 95% as determined by Bis-Tris PAGE - > 95% as determined by Bis-Tris PAGE
    Cor e Forma:White Lyophilized Powder
    Peso molecular:16.46 kDa (predicted) same as Tris-Bis PAGE result.
  • Midkine Protein, Mouse, Recombinant (His)


    Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic acid-responsive gene during embryogenesis, but currently viewed as
    Pureza:> 95% as determined by Bis-Tris PAGE - > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
    Cor e Forma:Transparent Solution
    Peso molecular:14.03 kDa (predicted). The protein migrates to 17-20 kDa based on Tris-Bis PAGE result.
  • Midkine Protein, Human, Recombinant (His & Avi), Biotinylated


    Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic acid-responsive gene during embryogenesis, but currently viewed as
    Cor e Forma:Lyophilized Powder
    Peso molecular:16.46 kDa (predicted) same as Tris-Bis PAGE result.
  • GSK1790627

    CAS:
    GSK1790627, the N-deacetylated metabolite of Trametinib, represents an orally active MEK inhibitor that promotes autophagy and triggers apoptosis [1].
    Fórmula:C24H21FIN5O3
    Cor e Forma:Solid
    Peso molecular:573.36
  • Anti-Midkine Antibody (5T766)


    Anti-Midkine Antibody (5T766) is an antibody targeting Midkine. Anti-Midkine Antibody (5T766) can be used in ELISA, IHC.
    Cor e Forma:Odour Liquid
  • Trametiglue

    CAS:
    Trametiglue, a potent Trametinib derivative, selectively targets KSR-MEK and RAF-MEK through unique binding.
    Fórmula:C25H24FIN6O5S
    Cor e Forma:Solid
    Peso molecular:666.46
  • Refametinib

    CAS:
    Refametinib (RDEA119) (RDEA119, Bay 86-9766) is an effective, ATP non-competitive and specific inhibitor of MEK1/2 (IC50: 19/47 nM).
    Fórmula:C19H20F3IN2O5S
    Pureza:99.85% - >99.99%
    Cor e Forma:Solid
    Peso molecular:572.34
  • PD98059

    CAS:
    PD98059 is an MEK inhibitor that inhibits MEK1 and MEK2 (IC50=2/50 μM) and is non-ATP-competitive.
    Fórmula:C16H13NO3
    Pureza:98.63% - >99.99%
    Cor e Forma:Green Solid
    Peso molecular:267.28